SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-136529
Filing Date
2018-04-27
Accepted
2018-04-27 06:09:03
Documents
5
Period of Report
2018-06-19
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d556898ddef14a.htm DEF 14A 565181
2 GRAPHIC g556898g58e28.jpg GRAPHIC 119378
3 GRAPHIC g556898g67c71.jpg GRAPHIC 8721
4 GRAPHIC g556898g87q22.jpg GRAPHIC 136944
5 GRAPHIC g556898g97s65.jpg GRAPHIC 57988
  Complete submission text file 0001193125-18-136529.txt   1011458
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36276 | Film No.: 18780869
SIC: 2834 Pharmaceutical Preparations